JUNEAU, Alaska Gov. Mike Dunleavy says Alaska will become the first state to drop eligibility requirements and allow anyone 16 or older who lives or works in the state
Press release content from Business Wire. The AP news staff was not involved in its creation.
Spero Health Expands Addiction Treatment Services with New Clinic Opening in Madison, Tennessee
March 8, 2021 GMT
BRENTWOOD, Tenn. (BUSINESS WIRE) Mar 8, 2021
Data from the Tennessee Department of Health (TDH) reveals there were 1,818 drug overdose deaths in 2018, the highest total since 2014. Responding to the growing demand for local, affordable, and comprehensive addiction treatment services, Spero Health, a national leader in providing care for individuals struggling with substance use disorders, announced it has fast tracked the opening of a new clinic in Madison. The new clinic located at 1035 E Old Hickory Blvd, will open on Thursday, March 11 th, and will offer a combination of in-person and telehealth visits. Spero Health has a growing network of over 50 clinics throughout Kentucky, Ohio, Tennessee, Virginia and Indiana, providing care for more than 9,000 patients. Individuals
â Europe struggles as infectious variants power virus surge
â Tibetan spiritual leader Dalai Lama gets coronavirus vaccine
â CDC Study: Mask mandates helps slow spread, indoor dining precarious
âââ
HEREâS WHAT ELSE IS HAPPENING:
CHICAGO â The first case of the Brazil variant in Illinois has been detected in a Chicago resident, health officials say.
City and state public health officials say Northwestern University researchers found the so-called P.1 variant in a test sample from a Chicago resident who came down with the disease. The infected person told contact tracers they hadnât recently traveled outside Illinois.
The P.1 strain was first found in Brazilian travelers who arrived in Tokyo in early January. It appeared in Minnesota later that month and has since been identified in several other states.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV .
Hyloris PharmaceuticalsMarch 5, 2021 GMT
Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets
Footprint across Europe now extended to a total of 20 EU member states
Maxigesic® IV offers a non-opioid alternative in post-operative pain management
Liège, Belgium – 5 March 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to bringing innovative treatments that offer added value to underserved patient populations, today announces that its partner AFT Pharmaceuticals (“AFT”) has signed an exclusive licensing agreement with Aguettant for Maxigesic IV, a novel, dual mode-of-action non-opioid pain treatment delivered through intravenous (IV) infusion, in eight Euro
WASHINGTON (AP) — Senate Democrats came out with their version of the $1.9 trillion coronavirus relief bill. A look at some of the major changes in the bill now being